Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues |
---|---|
6/30/2025 | $ 15.42M |
3/31/2025 | $ 6.4M |
12/31/2024 | $ 6.17M |
9/30/2024 | $ 6.74M |
6/30/2024 | $ 10.06M |
3/31/2024 | $ 12.99M |
12/31/2023 | $ 18.14M |
9/30/2023 | $ 22.24M |
6/30/2023 | $ 23.54M |
3/31/2023 | $ 33.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Sep 30, 2020
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.23K |
---|---|
min | $ -131.22M |
max | $ 2.76B |
average | $ 490.88M |
median | $ 156.47M |
std | $ 676.41M |